Department of Neurology and Institute of Neurology, Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Mov Disord. 2010 Apr 30;25(6):755-60. doi: 10.1002/mds.22646.
Mutation detection in the guanosine triphosphate cyclohydrolase I gene (GCH1) was performed from 4 female patients with dopa-responsive dystonia (DRD). DNA sequencing revealed the presence of four novel mutations including c.2T>C(M1T), c.239G>A(S80N), c.245T>C(L82P), and IVS5+3 del AAGT. These four mutations were not found in 100 genetically unrelated healthy controls with the same ethnic background band. In all 3 childhood-onset patients, DRD started in the legs, and missense mutations were located in the coding region of GCH1. Deletion mutation in the fifth exon-intron boundary of GCH1 was detected in the adult-onset patient. Although the data presented here do not provide sufficient evidence to establish a genotype-phenotype correlation of DRD, it is important to know the clinic features and genetic defects of DRD patients, which will help prenatal diagnosis, early diagnosis, evaluate the prognosis, and facilitate causal therapy with levodopa.
对 4 名多巴反应性肌张力障碍(DRD)女性患者进行了鸟苷三磷酸环化水解酶 I 基因(GCH1)的突变检测。DNA 测序显示存在 4 种新的突变,包括 c.2T>C(M1T)、c.239G>A(S80N)、c.245T>C(L82P)和 IVS5+3delAAGT。这 4 种突变在具有相同种族背景的 100 名无遗传相关性的健康对照者中均未发现。在所有 3 名儿童起病的患者中,DRD 始于腿部,错义突变位于 GCH1 的编码区。在成年起病的患者中检测到 GCH1 第五外显子-内含子边界的缺失突变。尽管这里提供的数据不足以确定 DRD 的基因型-表型相关性,但了解 DRD 患者的临床特征和遗传缺陷很重要,这有助于产前诊断、早期诊断、评估预后,并促进左旋多巴的因果治疗。